Nasdaq:US$13.30 (+0.08) | HKEX:HK$20.80 (-0.40) | AIM:£2.19 (+0.04)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2014-06-03

ASCO 2014: A phase 1b study of VEGFR inhibitor fruquintinib in patients with pretreated advanced colorectal cancer